- Jan 12, 2013
- 4,901
- 54,368
TSLA chart above
QQQ chart above
On Friday the market makers would really have loved to see TSLA descend to 420 and give them their 3rd big win week in a row. It didn't happen. Part of the reason was that the NASDAQ was a solid climber throughout the day, as expressed in the QQQ chart above. You have to give the pirates points for trying, however. Look at those two massive Mandatory Morning Dips that were apparently based off tiny and momentary dips in the NASDAQ. Ditto with afternoon QQQ dips, as well.
I had speculated that with Pierre Farragu upping his price target, changing from hold to buy, and signalling that he didn't think waiting for a dip before the 3Q ER was a reasonable expectation any more, and then on Thursday hearing the date of the 3Q ER is a relatively soon Oct 21, I thought that some of the big dog investors who wanted into TSLA prior to the ER would start buying and volume would pick up enough for the manipulators to encounter problems.
Actually, the opposite happened. Volume was a tiny 28.3 million shares. When you look at some of the clear manipulations during the day that would depend upon short-selling, the number of legitimate long sales would be noticeably smaller than even that 28M shares. What happened is that the current TSLA shareholders became all the more determined to HODL on a day when the NASDAQ gave little opportunity for successful pushdowns of the stock price. Thus, with nobody wanting to sell at these prices and with no macro action that would allow the manipulations to gain any traction, TSLA climbed today. Bravo!
Coronavirus Update
As we progress into a cooler time of the year there's reason to see an upturn in COVID 19 new cases in the United States.
You can see from the top chart there's been a bit of an uptrend lately, but probably nothing to spook the market yet, particularly with the daily deaths still in a slight downtrend (they lag the new cases by a few weeks).
This past week, the POTUS stated how quickly the Regeneron monoclonal antibody infusion managed to improve his symptoms. Both Regeneron and Eli Lilly have large quantities of monoclonal antibodies ready for distribution once the FDA awards emergency authority to distribute. Eli Lilly's single antibody product wasn't as powerful as Regeneron's product and Eli Lilly went back to the lab, created a cocktail with two antibodies in it, and their new product appears to be robust. The appearance of effective, safe monoclonal antibodies could be a game changer and something that could boost the market, but we may see the FDA trying to avoid granting authority before the election so as to appear unswayed by political pressure from the current administration. If that occurs, we will still see a potential bump in the market when these products gain emergency authority at a later date.
My personal opinion is that the bar for therapeutics such as monoclonal antibodies can be much lower than the bar for vaccines, because those with COVID 19 are in a substantially higher risk situation than a healthy person taking a vaccine. If the risk of taking the monoclonal antibody is substantially outweighed by the benefit, the FDA should move forward with emergency authority.
Looking at the tech chart, notice that the lower bollinger band has climbed to nearly reach the 50 day moving average at about 390. This combination of two reliable sources of support adds up to a really excellent support mechanism at the moment, if needed. Zooming out, notice that consolidation periods of up to a month have been pretty common during this massive climb. Since September we've seen two notable dips: the first was the fall from 502 after TSLA announced a $5 billion cap raise at about the same time that TSLA got snubbed by the S&P500 committee. The 2nd dip was the battery day dip. Take out some of the short-term volatility and TSLA has been trading in the low-to-mid 400s for over a month now and only 8 trading days remain before the 3Q ER. Tick, tick, tick.
For the week, TSLA closed at 433.95, up 18.86 from last Friday's 415.09. It's been a good week with the stock price hovering above the mid bollinger band and that mid bollinger band curving upward. Have a great weekend!
Conditions:
* Dow up 161 (0.57%)
* NASDAQ up 159 (1.39%)
* TSLA 433.95, up 8.03 (1.89%)
* TSLA volume 28.3M shares
* Oil 40.60
* Percent of TSLA selling tagged to shorts: 37%
Last edited: